Tuesday, August 28, 2018 12:52:39 PM
Recent OGN News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:21:47 PM
- オルガノンがDermavantを買収し、画期的な皮膚科治療薬VTAMA®(タピナロフ)クリーム1%を取得 • Business Wire • 09/19/2024 06:30:00 PM
- Organon acquiert Dermavant et sa thérapie dermatologique innovante, la crème VTAMA® (tapinarof), 1 % • Business Wire • 09/19/2024 12:00:00 PM
- Organon erwirbt Dermavant und dessen innovative dermatologische Behandlung VTAMA® (Tapinarof) Creme, 1 % • Business Wire • 09/19/2024 12:00:00 PM
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% • Business Wire • 09/18/2024 11:30:00 AM
- Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1% • GlobeNewswire Inc. • 09/18/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:32:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:31:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:31:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:31:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:30:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 08:30:42 PM
- オルガノンとリリーが片頭痛治療薬の商業化契約を拡大、11の新しい市場に参入 • Business Wire • 08/21/2024 12:13:00 AM
- Organon und Lilly erweitern Migräne-Vermarktungsvereinbarung auf 11 weitere Märkte • Business Wire • 08/20/2024 09:06:00 PM
- Organon y Lilly amplían su acuerdo de comercialización para la migraña a otros 11 mercados • Business Wire • 08/20/2024 07:34:00 PM
- Organon et Lilly élargissent l'accord de commercialisation pour la migraine à 11 marchés supplémentaires • Business Wire • 08/20/2024 02:20:00 PM
- Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets • Business Wire • 08/20/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 12:07:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 11:39:19 AM
- Organon Reports Results for the Second Quarter Ended June 30, 2024 • Business Wire • 08/06/2024 11:30:00 AM
- US Index Futures Rise After Market Sell-off, Oil Prices Trim Losses • IH Market News • 08/06/2024 09:49:06 AM
- Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024 • Business Wire • 07/09/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 07:17:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 07:16:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 07:16:19 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM